The Analyst Verdict: UnitedHealth Group In The Eyes Of 11 Experts
Portfolio Pulse from Benzinga Insights
Recent analysis of UnitedHealth Group (UNH) by 11 analysts shows a mix of bullish to indifferent sentiments, with a shift towards more cautious ratings in the last 30 days. The average 12-month price target is now $587.36, down from $624.67, indicating a 5.97% decrease. Analysts' actions range from maintaining to lowering ratings, with price targets adjusted accordingly. UnitedHealth Group, a major health insurer, has shown strong financial performance, including a 14.06% revenue growth and a net margin of 5.78%, but carries a notable debt-to-equity ratio of 0.7.
April 04, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
UnitedHealth Group's stock may face short-term pressure due to the lowered average price target and mixed analyst sentiments, despite strong financial performance.
The decrease in the average price target and the shift towards more cautious ratings by analysts suggest potential short-term headwinds for UNH stock. However, the company's strong financial performance, including significant revenue growth and net margin, provides a solid foundation that may mitigate negative impacts.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100